Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 22, 2007

View Archived Issues

Preclinical profile of novel oncolytic measles virus

Vivus initiates phase III CONQUER trial of Qnexa in obese patients

Schering-Plough acquires Organon BioSciences from Akzo Nobel for EUR 11 billion

Aradigm initiates phase II trial of inhaled liposomal ciprofloxacin for cystic fibrosis

BioAlliance completes patient enrollment in phase III clinical trial of Loramyc

Sinovac provides update on clinical trials of H5N1 pandemic influenza vaccines

Clinical trials show anti-hepatitis C virus activity of telaprevir therapy

Antimalarial noninferiority of Coarsucam and Coartem demonstrated

Nitazoxanide improves responses to standard care in HCV genotype 4 patients

Objective responses seen with SGN-35 in phase I Hodgkin's lymphoma study

Raven updates phase I clinical trial results of RAV-12

Sanofi-aventis presents third quarter 2007 results

Recent patents disclose novel analgesic agents

The FDA accepts for filing CV Therapeutics' sNDA and NDA for Ranexa

Amarin completes data review of phase III TREND-HD clinical trial of Miraxion

Studies reveal efficacy of golimumab in ankylosing spondylitis, psoriatic arthritis

Improvement seen with baminercept in rheumatoid arthritis patients

Antichlamydial treatment does not improve intermittent claudication symptoms

First-in-human study assesses effects of SB-705498 on pain, hyperalgesia

Tiagabine ineffective in cocaine dependence study

Topigen initiates phase II proof-of-concept trial of TPI-1020 for COPD

Biogen Idec and Neurimmune enter agreement for antibodies for Alzheimer's disease

Pacgen initiates phase IIb clinical trial of PAC-113 for oral candidiasis

GSK and Genmab initiate two phase III studies of ofatumumab in rheumatoid arthritis

Antisoma provides update on clinical development of its anticancer compounds

Array BioPharma initiates phase II trial of ARRY-797 for dental pain

Cytochroma initiates phase I/II clinical trial of CTAP-101 capsules

Novartis withdraws application to extend marketing authorization for Zometa

Recent GSK patents impart new agents for HIV infection

New diagnostic agents reported in recent U.S. Department of Health & Human Services patent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 4, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...